Monoquaternary ammonium derivatives inhibit growth of protozoan parasites

Parasitology International

Volumn 57, Issue 2, 2008, Pages 132-137

  Bahamontes Rosa, N ^a   Robin, A ^b   Ambrosio, A R ^c   Messias Reason, I ^a,c   Beitz, E ^d   Flitsch, S L ^b   Kun, J F J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Clinical Hospital   (Brazil)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

Aquaporin; Leishmania braziliensis; Monoquaternary ammonium; Phospholipid metabolism; Plasmodium falciparum

Indexed keywords

AMMONIUM DERIVATIVE;

ANTIMALARIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEISHMANIA BRAZILIENSIS; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; ANTIPROTOZOAL AGENTS; CELL LINE, TUMOR; ERYTHROCYTES; HUMANS; JURKAT CELLS; LEISHMANIA BRAZILIENSIS; PARASITIC SENSITIVITY TESTS; PHOSPHOLIPIDS; PLASMODIUM FALCIPARUM; QUATERNARY AMMONIUM COMPOUNDS;

LEISHMANIA BRAZILIENSIS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 40749109892     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2007.09.006     Document Type: Article

References (23)

1. Guinovart C., Navia M.M., Tanner M., and Alonso P.L. Malaria: burden of disease. Curr Mol Med 6 (2006) 137-140
2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27 (2004) 305-318
3. Ashford R.W. The leishmaniasis as emerging and reemerging zoonoses. Int J Parasitol 30 (2000) 1269-1281
4. Turetz M.L., Machado P.R., Ko A.I., Alves F., Bittencourt A., Almeida R.P., et al. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 186 (2002) 1829-1834
5. Guerin P.J., Olliaro P., Sundar S., Boelaert M., Croft S.L., Desjeux P., et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2 (2002) 494-501
6. Croft S.L., Sundar S., and Fairlamb A.H. Drug resistance in leishmaniasis. Clin Microbiol Rev 19 (2006) 111-126
7. Mitamura T., and Palacpac N.M. Lipid metabolism in Plasmodium falciparum-infected erythrocytes: possible new targets for malaria chemotherapy. Microbes Infect 5 (2003) 545-552
8. Wassef M.K., Fioretti T.B., and Dwyer D.M. Lipid analyses of isolated surface membranes of Leishmania donovani promastigotes. Lipids 20 (1985) 108-115
9. Ancelin M.L., and Vial H.J. Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transport. Antimicrob Agents Chemother 29 (1986) 814-820
10. Zufferey R., and Mamoun C.B. Choline transport in Leishmania major promastigotes and its inhibition by choline and phosphocholine analogs. Mol Biochem Parasitol 125 (2002) 127-134
11. Choubey V., Maity P., Guha M., Kumar S., Srivastava K., Puri S.K., et al. Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism. Antimicrob Agents Chemother 51 (2007) 696-706
12. Ancelin M.L., Calas M., Bompart J., Cordina G., Martin D., Ben Bari M., et al. Antimalarial activity of 77 phospholipid polar head analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth. Blood 91 (1998) 1426-1437
13. Ancelin M.L., Calas M., Vidal-Sailhan V., Herbute S., Ringwald P., and Vial H.J. Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob Agents Chemother 47 (2003) 2590-2597
14. Ancelin M.L., Calas M., Bonhoure A., Herbute S., and Vial H.J. In vivo antimalarial activities of mono-and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism. Antimicrob Agents Chemother 47 (2003) 2598-2605
15. Wengelnik K., Vidal V., Ancelin M.L., Cathiard A.M., Morgat J.L., Kocken C.H., et al. A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science 295 (2002) 1311-1314
16. Calas M., Ancelin M.L., Cordina G., Portefaix P., Piquet G., Vidal-Sailhan V., et al. Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts. J Med Chem 43 (2000) 505-516.
17. Trager W., and Jensen J.B. Human malaria parasites in continuous culture. Science 193 (1976) 673-675
18. Lambros C., and Vanderberg J.P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65 (1979) 418-420
19. Noedl H., Wernsdorfer W.H., Miller R.S., and Wongsrichanalai C. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob Agents Chemother 46 (2002) 1658-1664.
20. Noedl H., Bronnert J., Yingyuen K., Attlmayr B., Kollaritsch H., and Fukuda M. Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother 49 (2005) 3575-3577
21. Calas M., Cordina G., Bompart J., Ben Bari M., Jei T., Ancelin M.L., et al. Antimalarial activity of molecules interfering with Plasmodium falciparum phospholipid metabolism. Structure-activity relationship analysis. J Med Chem 40 (1997) 3557-3566
22. Detmers F.J., de Groot B.L., Müller E.M., Hinton A., Flitsch S.L., Grubmüller H., et al. Quaternary ammonium compounds as water channel blockers: specificity, potency and site of action. J Biol Chem (2006)
23. Hansen M., Kun J.F., Schultz J.E., and Beitz E. A single, bi-functional aquaglyceroporin in blood-stage Plasmodium falciparum malaria parasites. J Biol Chem 277 (2002) 4874-4882.